Suppression of glioma invasion and growth by adenovirus-mediated delivery of a bicistronic construct containing antisense uPAR and sense p16 gene sequences (Journal article)

Adachi, Y./ Chandrasekar, N./ Kin, Y./ Lakka, S. S./ Mohanam, S./ Yanamandra, N./ Mohan, P. M./ Fuller, G. N./ Fang, B./ Fueyo, J./ Dinh, D. H./ Olivero, W. C./ Tamiya, T./ Ohmoto, T./ Kyritsis, A. P./ Rao, J. S.

Our previous studies showed that the urokinase-type plasminogen activator receptor (uPAR) and the p16 tumor suppressor gene play a significant role in glioma invasion. We expected that downregulation of uPAR and overexpression of p16 using a bicistronic vector might cause a additive and cooperative effect in the suppression of glioma invasion and growth. The bicistronic construct (Ad-uPAR/p16)-infected glioblastoma cell lines had significantly lower levels of uPAR and higher levels of p16 than controls. Cell cycle analysis showed the bicistronic vector caused G0/G1 arrest of the cell cycle. In vitro glioblastoma cell growth and invasiveness were inhibited in Ad-uPAR/p16-infected cells compared with controls. Ad-uPAR/p16 suppressed the tumor growth of glioblastoma cell lines in an ex vivo intracerebral tumor model and an in vivo subcutaneous tumor model. Our results support the therapeutic potential of simultaneously targeting uPAR and p16 in the treatment of gliomas.
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adenoviridae/genetics,Apoptosis,Brain Neoplasms/*pathology/therapy,*Cell Cycle Proteins,Cyclin-Dependent Kinase Inhibitor p16/*physiology,*DNA-Binding Proteins,E2F Transcription Factors,Gene Expression Regulation, Neoplastic,*Gene Therapy,Genes,*Genes, p16,Genetic Vectors/genetics,Glioblastoma/*pathology/therapy,Humans,*Neoplasm Invasiveness,Neoplasm Proteins/*antagonists & inhibitors/genetics/physiology,Neoplasm Transplantation,Oligodeoxyribonucleotides, Antisense/genetics/*therapeutic use,Receptors, Cell Surface/*antagonists & inhibitors/genetics/physiology,Receptors, Urokinase Plasminogen Activator,Recombinant Fusion Proteins/physiology,Retinoblastoma Protein/metabolism,Transcription Factors/metabolism,Xenograft Model Antitumor Assays
ISSN: 0950-9232
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Adachi-2002-Suppression of gliom.pdf508.51 kBAdobe PDFView/Open    Request a copy

 Please use this identifier to cite or link to this item:
  This item is a favorite for 0 people.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.